Skip to main content

Table 2 Viability of BM-MSCs (n = 6) and AT-MSCs (n = 6) cultured under hypoxic or normoxic conditions

From: Effect of hypoxia on equine mesenchymal stem cells derived from bone marrow and adipose tissue

  

A

B

C

D

  

BM-MSC

AT-MSC

Normoxia

Hypoxia

  

Normoxia

Hypoxia

Normoxia

Hypoxia

BM-MSC

AT-MSC

BM-MSC

AT-MSC

Day 1

PI+

13.64 ± 2,03

12.06 ± 3.89

46.64 ± 26.38

72.24 ± 17.20

13.64 ± 2,03 a

46.64 ± 26.38 b

12.06 ± 3.89 a

72.24 ± 17.20 b

AnV-PI-

81.92 ± 2.74

81.39 ± 8.51

47.86 ± 23.61 a

21.79 ± 12.35 b

81.92 ± 2.74 a

47.86 ± 23.61 b

81.39 ± 8.51 a

21.79 ± 12.35 b

AnV+PI-

4.44 ± 1.27

6.52 ± 4.94

5.60 ± 2.69

6.05 ± 6.04

4.44 ± 1.27

5.60 ± 2.69

6.52 ± 4.94

6.05 ± 6.04

Day 2

PI+

15,02 ± 3.05

13,97 ± 6.37

28.01 ± 11.11

52.85 ± 25.16

15,02 ± 3.05 a

28.01 ± 11.11 b

13,97 ± 6.37 a

52.85 ± 25.16 b

AnV-PI-

81.91 ± 3.67

81.72 ± 7.00

65.45 ± 12.05 a

39.31 ± 22.23 b

81.91 ± 3.67 a

65.45 ± 12.05 b

81.72 ± 7.00 a

39.31 ± 22.23 b

AnV+PI-

3.07 ± 0.94

4.53 ± 1.52

6.54 ± 2.53

9.31 ± 5.23

3.07 ± 0.94 a

6.54 ± 2.53 b

4.53 ± 1.52

9.31 ± 5.23

Day 3

PI+

15.44 ± 7.98

14.07 ± 5.08

21,29 ± 3.94 a

45.97 ± 19.78 b

15.44 ± 7.98

21,29 ± 3.94

14.07 ± 5.08 a

45.97 ± 19.78 b

AnV-PI-

77.84 ± 3.96

75.04 ± 11.65

74.28 ± 3.13 a

46.24 ± 18.6 b

77.84 ± 3.96 a

74.28 ± 3.13 b

75.04 ± 11.65 a

46.24 ± 18.61 b

AnV+PI-

6.71 ± 2.16

10.86 ± 7.19

4.43 ± 1.62

7.83 ± 5.23

6.71 ± 2.16

4.43 ± 1.62

10.86 ± 7.19

7.83 ± 5.23

Day 4

PI+

14.43 ± 6.25

14.60 ± 7.41

14.64 ± 3.60 a

25.39 ± 11.67 b

14.43 ± 6.25

14.64 ± 3.60

14.60 ± 7.41 a

25.39 ± 11.67 b

AnV-PI-

76.82 ± 5.89

77.11 ± 7.49

80.98 ± 2.88

68.31 ± 11.32

76.82 ± 5.89

80.98 ± 2.88

77.11 ± 7.49

68.31 ± 11.32

AnV+PI-

8.74 ± 4.06

8.31 ± 3.15

4.41 ± 2.40

6.30 ± 5.49

8.74 ± 4.06 a

4.41 ± 2.40 b

8.31 ± 3.15

6.30 ± 5.49

Day 5

PI+

8.7 ±3.27

7.34 ± 2.61

8.29 ± 1.80 a

17.82 ± 7.72 b

8.7 ±3.27

8.29 ± 1.80

7.34 ± 2.61 a

17.82 ± 7.72 b

AnV-PI-

83.03 ± 4.91

82.28 ± 8.29

89.64 ± 1.54 a

77.37 ± 6.67 b

83.03 ± 4.91 a

89.64 ± 1.54 b

82.28 ± 8.29 a

77.37 ± 6.67 b

AnV+PI-

8.28 ± 3.49

10.37 ± 7.60

2.06 ± 0.73

4.81 ± 4.22

8.28 ± 3.49 a

2.06 ± 0.73 b

10.37 ± 7.60

4.81 ± 4.22

Day 6

PI+

8.04 ± 4.37

10.27 ± 1.59

8.64 ± 1.51

14.14 ± 8,83

8.04 ± 4.37

8.64 ± 1.51

10.27 ± 1.59

14.14 ± 8,83

AnV-PI-

84.79 ± 7.37

77.76 ± 9.44

89.18 ± 1.32

81.43 ± 10.06

84.79 ± 7.37

89.18 ± 1.32

77.76 ± 9.44

81.43 ± 10.06

AnV+PI-

7.16 ± 3.46

11.98 ± 7.96

2.14 ± 0.66

4.42 ± 2.71

7.16 ± 3.46 a

2.14 ± 0.66 b

11.98 ± 7.96

4.42 ± 2.71

Day 7

PI+

9.77 ± 5,27

10.95 ± 4.29

8.05 ± 4.28 a

15.69 ± 8.96 b

9.77 ± 5,27

8.05 ± 4.28

10.95 ± 4.29

15.69 ± 8.96

AnV-PI-

83.29 ± 6.91

80.45 ± 5.98

85.67 ± 7.91

78.05 ± 7.77

83.29 ± 6.91

85.67 ± 7.91

80.45 ± 5.98

78.05 ± 7.77

 

AnV+PI-

6.92 ± 3.40

8.65 ± 7.26

6.14 ± 4.32

6.96 ± 1.16

6.92 ± 3.40

6.14 ± 4.32

8.65 ± 7.26

6.96 ± 1.16

  1. Viability data are represented as the mean ± standard deviation. Non-viable cells (PI+), viable cells (AnV-PI-) and apoptotic cells (AnV+PI-) were analysed for 7 days. Superscripted bold data (“a” and “b”) are significantly different. (A) Compares normoxic and hypoxic conditions of BM-MSCs; (B) compares normoxic and hypoxic conditions of AT-MSCs; (C) compares BM-MSCs and AT-MSCs in normoxic conditions; and (D) compares BM-MSCs and AT-MSCs in hypoxic conditions.